The extracellular matrix: a dynamic niche in cancer progression, J Cell Biol, vol.196, pp.395-406, 2012. ,
Matrix crosslinking forces tumor progression by enhancing integrin signaling, Cell, vol.139, pp.891-906, 2009. ,
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression, Nature Medicine, vol.22, issue.5, pp.497-505, 2016. ,
The myofibroblast: Paradigm for a mechanically active cell, Journal of Biomechanics, vol.43, issue.1, pp.146-155, 2010. ,
Tensional homeostasis and the malignant phenotype, Cancer Cell, vol.8, issue.3, pp.241-254, 2005. ,
Role of YAP/TAZ in mechanotransduction, Nature, vol.474, pp.179-83, 2011. ,
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts, Nature Cell Biology, vol.15, issue.6, pp.637-646, 2013. ,
Framework to function: mechanosensitive regulators of gene transcription, Cell Mol Biol Lett, vol.21, p.28, 2016. ,
Mutual dependence of the MRTF?SRF and YAP?TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics, Genes & Development, vol.31, issue.23-24, pp.2361-2375, 2017. ,
The Hippo effector YAP promotes resistance to RAF-and MEK-targeted cancer therapies, Nat Genet, vol.47, pp.250-256, 2015. ,
Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation, EMBO J, vol.35, pp.462-78, 2016. ,
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state, Nat Commun, vol.6, p.6683, 2015. ,
From melanocytes to melanomas, Nature Reviews Cancer, vol.16, issue.6, pp.345-358, 2016. ,
Systematic classification of melanoma cells by phenotype-specific gene expression mapping, Pigment Cell & Melanoma Research, vol.25, issue.3, pp.343-353, 2012. ,
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq, Science, vol.352, pp.189-96, 2016. ,
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress, Cancer Cell, vol.33, issue.5, pp.890-904.e5, 2018. ,
From genes to drugs: targeted strategies for melanoma, Nat Rev Cancer, vol.12, pp.349-61, 2012. ,
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy, Cancer Discovery, vol.4, issue.1, pp.80-93, 2013. ,
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance, Cell, vol.162, pp.1271-85, 2015. ,
JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma, Cell Discov, vol.2, p.16028, 2016. ,
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation, Nature, vol.468, issue.7326, pp.973-977, 2010. ,
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K, Cancer Cell, vol.18, pp.683-95, 2010. ,
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma, Cancer Discov, vol.3, pp.158-67, 2013. ,
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma, Nature Communications, vol.5, issue.1, p.5712, 2014. ,
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma, Nature, vol.508, issue.7494, pp.118-122, 2014. ,
Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-?B signaling pathway, Oncogene, vol.38, issue.30, pp.5873-5889, 2019. ,
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion, Nature, vol.487, issue.7408, pp.500-504, 2012. ,
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance, Nature, vol.532, issue.7598, pp.250-254, 2016. ,
The Immune Microenvironment Confers Resistance to MAPK Pathway Inhibitors through Macrophage-Derived TNF, Cancer Discovery, vol.4, issue.10, pp.1214-1229, 2014. ,
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition, Journal of Experimental Medicine, vol.214, issue.6, pp.1691-1710, 2017. ,
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin ?1/FAK Signaling, Cancer Cell, vol.27, issue.4, pp.574-588, 2015. ,
Tumor-Derived Fibronectin Is Involved in Melanoma Cell Invasion and Regulated by V600E B-Raf Signaling Pathway, Journal of Investigative Dermatology, vol.127, issue.2, pp.400-410, 2007. ,
The Matrisome:In SilicoDefinition andIn VivoCharacterization by Proteomics of Normal and Tumor Extracellular Matrices, Molecular & Cellular Proteomics, vol.11, issue.4, p.M111.014647, 2011. ,
Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies, Molecular Cancer Therapeutics, vol.17, issue.7, pp.1416-1429, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02285825
Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis, Nat Commun, vol.6, p.6993, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01295443
Preparation of Extracellular Matrices Produced by Cultured and Primary Fibroblasts, Current Protocols in Cell Biology, vol.33, issue.1, pp.10.9.1-10.9.21, 2006. ,
LIF mediates proinvasive activation of stromal fibroblasts in cancer, Cell Rep, vol.7, pp.1664-78, 2014. ,
Measurement of cell traction forces with ImageJ, Methods Cell Biol, vol.125, pp.269-87, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01142591
Preparation of hydrogel substrates with tunable mechanical properties, Curr Protoc Cell Biol, vol.10, p.6, 2010. ,
CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction, Cancer Res, vol.74, pp.6878-89, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02526881
Toward Minimal Residual Disease-Directed Therapy in Melanoma, Cell, vol.174, p.19, 2018. ,
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension, J Clin Invest, vol.126, pp.3313-3348, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02479282
Mechanotransduction and extracellular matrix homeostasis, Nature Reviews Molecular Cell Biology, vol.15, issue.12, pp.802-812, 2014. ,
Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway, J Cell Sci, vol.120, pp.1801-1810, 2007. ,
BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape, J Invest Dermatol, vol.135, pp.3115-3139, 2015. ,
Heterogeneous tumor subpopulations cooperate to drive invasion, Cell Rep, vol.8, pp.688-95, 2014. ,
B-RAF regulation of Rnd3 participates in actin cytoskeletal and focal adhesion organization, Mol Biol Cell, vol.19, pp.498-508, 2008. ,
Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells, Oncogene, vol.35, pp.1225-1260, 2016. ,
Modulation of matrix elasticity with PEG hydrogels to study melanoma drug responsiveness, Biomaterials, vol.35, pp.4310-4318, 2014. ,
Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening, Biomaterials, vol.35, pp.5749-59, 2014. ,
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells, Cell, vol.147, pp.759-72, 2011. ,
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in, Cancer. Cell Rep, vol.25, p.5, 2018. ,
Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing, Oncogene, vol.37, pp.3166-82, 2018. ,
Therapy-induced tumour secretomes promote resistance and tumour progression, Nature, vol.520, pp.368-72, 2015. ,
Kruskall-Wallis test. (K) Proposed model for the biomechanical reprogramming of melanoma cell induced by MAPK targeted therapies. The scheme shows the reciprocal YAP/MRTF-dependent feed-forward loop between drug-exposed or resistant MITF low /AXL high melanoma cells and ECM remodeling to increase tumor tissue stiffening, vol.001 ,